Intracavernosal injection therapy and surgical therapy in diabetic patients with erectile dysfunction

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 1, 2002, Pages 53-57

  Savoca, G ^a   Silvestre, G ^a   Belgrano, E ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Diabetes mellitus; Erectile dysfunction; Intracavernosal injection; Surgical therapy; Therapy

Indexed keywords

ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; METARAMINOL; PAPAVERINE; PHENPROCOUMON; PHENTOLAMINE; PHENYLEPHRINE; PROSTAGLANDIN; PROSTAGLANDIN E1; WARFARIN;

ARTICLE; BLEEDING; CONTROLLED STUDY; DIABETES MELLITUS; DRUG FORMULATION; DRUG MECHANISM; ERECTILE DYSFUNCTION; FIBROSIS; HUMAN; INJECTION PAIN; MALE; PATHOPHYSIOLOGY; PENIS PROSTHESIS; PREMATURE EJACULATION; PRIORITY JOURNAL; SEXUAL FUNCTION; VACUUM;

DIABETES COMPLICATIONS; HUMANS; IMPOTENCE; INJECTIONS; MALE; PENILE IMPLANTATION; PENIS; URETHRA; VASODILATOR AGENTS;

EID: 0036124704     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The prevalence of diabetic impotence
2. Erectile dysfunction in diabetic subjects in Italy
3. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: Double blind placebo-controlled trial
4. Endogenous sex hormones in older adult men with diabetes mellitus
5. Intracavernous injection of papaverine for erectile failure
6. 1 in erectile failure a survey of world-wide experience
7. Autoinjection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence
8. The efficacy and acceptance of intracavernous autoinjection therapy with the combination of papaverine/phentolamine. A prospective multicenter trial in 60 patients
9. 1 in human penile erection
10. 1 for organic impotence
11. 1: Introductory remarks
12. Modulation of noradrenaline release in human corpus cavernosum by presynaptic prostaglandin receptors
13. Tissue Angiotensin II as a modulator of erectile function. I Angiotensin peptide content, secretion and effects in the corpus cavernosum
14. +-channel activity in cultured human corporal smooth muscle cells
15. E-series prostaglandins and arginine vasopressin in the modulation of male sexual behavior
16. 1 in human corpus cavernosum smooth muscle: Mechanism of penile ischemia associated fibrosis
17. Intracavernous injection of prostaglandin E1 in impotent diabetic men
18. Intracavernosal vasoactive agents: Comparison of diabetic and non-diabetic impotent men
19. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
20. Intracavernosal self injection therapy in men with erectile dysfunction: Satisfaction and attrition in 119 patients
21. Intracavernosal therapy for erectile failure. Impact of treatment and reasons for drop-out and dissatisfaction
22. Treatment of erectile dysfunction by the medicated urethral system for erection (MUSE)
23. 1 for treatment of erectile dysfunction
24. Minimally invasive therapies in the treatment of erectile dysfunction in anticoagulated cases: A study of satisfaction and safety
25. Offene Multicenterstudie zur Differenztialdiagnostik der erektilen Dysfunktion mit eiener Papaverin/Phentolamin-Kombination (By 023)
26. Risk factors for penile prosthetic infection